[1] Hossain Mz, Kyomen S, Tanne K. Biologic responses of autogenous bone and beta-tricalcium phosphate ceramics transplanted into bone defects to orthodontic forces [J]. Cleft Palate Craniofac J, 1996, 33(4): 277-283. [2] Liao HT, Chen CH, Bergeron L, et al. Alveolar bone grafting in the treatment of midline alveolar cleft and diastema in incomplete median cleft lip [J]. Int J Oral Maxillofac Surg, 2008, 37(10): 886-891. [3] Kawamoto T, Motohashi N, Kitamura A, et al. Experimental tooth movement into bone induced by recombinant human bone morphogenetic protein-2[J]. Cleft Palate Craniofac J, 2003, 40(5): 538-543. [4] Tanimoto K, Sumi K, Yoshioka M, et al. Experimental tooth movement into new bone area regenerated by use of bone marrow-derived mesenchymal stem cells [J]. Cleft Palate Craniofac J, 2013 Jun 19. [Epub ahead of print] [5] Uji M. Histological study on experimental tooth movement in alveolar bone defects implanted with decalcified bone powder [J]. Kokubyo Gakkai Zasshi, 1996, 63(1): 208-221. [6] Seifi M, Ghoraishian SA. Determination of orthodontic tooth movement and tissue reaction following demineralized freeze-dried bone allograft grafting intervention [J]. Dent Res J (Isfahan), 2012, 9(2): 203-208. [7] Ren Y, Vissink A. Cytokines in crevicular fluid and orthodontic tooth movement [J]. Eur J Oral Sci, 2008, 116(2): 89-97. [8] 许悦, 陈振琦, 吴军, 等. 唇腭裂合并的单侧牙槽突裂大鼠模型的建立和稳定性研究 [J]. 上海交通大学学报(医学版), 2010, 30(9): 1111-1114. [9] Kawamoto T, Motohashi N, Kitamura A, et al. A histological study on experimental tooth movement into bone induced by recombinant human bone morphogenetic protein-2 in beagle dogs [J]. Cleft Palate Craniofac J, 2002, 39(4): 439-448. [10] 李壬媚, 许悦, 陈振琦, 等. 不同时机牙移动对SD大鼠牙槽突裂植骨区骨改建的影响[J].中国口腔颌面外科杂志,2012,10(2): 96-100. [11] Fujita S, Yamaguchi M, Utsunomiya T, et al. Low-energy laser stimulates tooth movement velocity via expression of RANK and RANKL [J]. Orthod Craniofac Res, 2008, 11(3): 143-155. [12] Mason DJ, Hillam RA, Skerry TM. Constitutive in vivo mRNA expression by osteocytes of beta-actin, osteocalcin, connexin-43, IGF-I, c-fos and c-jun, but not TNF-alpha nor tartrate-resistant acid phosphatase [J]. J Bone Miner Res, 1996, 11(3): 350-357. [13] Kiechl S, Werner P, Knoflach M, et al. The osteoproteger in/RANK/RANKL system: a bone key to vascular disease [J]. Expert Rev Cardiovasc Ther, 2006, 4(6): 801-811. [14] Fuller K, Wong B, Fox S, et al. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts [J]. J Exp Med, 1998, 188(5): 997-1001. [15] Bronckers Al, Sasaguri K, Engelse MA. Transcription and immunolocalization of Runx2/Cbfa1/Pebp2alphaA in developing rodent and human craniofacial tissues: further evidence suggesting osteoclasts phagocytose osteocytes [J]. Microsc Res Tech, 2003, 61(6): 540-548. |